Search Results for "poverty guidelines"
Displaying 21 - 40 of 75 results. 20 results shown per page. Page 2 of 4.
CDC/ATSDR — Chesapeake Well Site Health Consultation: Interim Response, November 19,2012
Publication Date
November 19,2012 Paul Hagemeier Chesapeake Energy CorporationP.O. Box 18496Oklahoma City, OK 73154-0496 Dear Mr. Hagemeier
CDC/ATSDR — Chesapeake Well Site Health Consultation: Interim Response, September 20, 2012
Publication Date
September 20, 2012 Paul Hagemeier Chesapeake Energy CorporationP.O. Box 18496Oklahoma City, OK 73154-0496 Dear Mr. Hagemeier
CDC/ATSDR — Chesapeake Well Site Health Consultation: Interim Response, July 20. 2012
Publication Date
July 20. 2012 Paul I HagemeierChesapeake Energy CorporationP.O. Box 18496Oklahoma City, OK 73154-0496 Dear Mr. Hagemeier
CDC/ATSDR — Chesapeake Well Site Health Consultation: Interim Response, July 16, 2013
Publication Date
July 16, 2013 Mr. Paul D. HagemeierVice President- Regulatory ComplianceChesapeake Energy CorporationP.O. Box 18496Oklahoma City, OK 73154-0496 Mr. Hagemeier:
CDC/ATSDR — Chesapeake Well Site Health Consultation: Interim Response, January 17,2013
Publication Date
January 17,2013 Paul Hagemeier Chesapeake Energy CorporationP.O. Box 18496Oklahoma City, OK 73154-0496 Dear Mr. Hagemeier,
CDC/ATSDR — Chesapeake Well Site Health Consultation: Interim Response, September 13, 2013
Publication Date
September 13, 2013 Mr. Paul D. HagemeierVice President- Regulatory ComplianceChesapeake Energy CorporationP.O. Box 18496Oklahoma City, OK 73154-0496 Mr. Hagemeier:
NTP — Naphthalene: HHS Response to Rfr
Publication Date
Date: November 2, 2005 To: Ms. Courtney M. Price, Vice President, CHEMSTAR, American Chemistry Council Re: Naphthalene Information Quality Act Request for Reconsideration submitted February 18, 2005 Dear Ms. Price:
NTP — Naphthalene: Interim Response, August 26, 2005
Publication Date
From: August 26, 2005 To: Ms. Courtney M. Price, Vice President, CHEMSTAR, American Chemistry Council Re: February 22, 2005, Request for Reconsideration Submitted by the American Chemistry Council Regarding Naphthalene Dear Ms. Price:
NTP — Naphthalene: Interim Response, June 24, 2005
Publication Date
From: National Institutes of Health, Office of Science Policy To: Ms. Courtney M. Price, President, CHEMST AR American Chemistry Council Date: June 24, 2005 Re: February 22, 2005, Request for Reconsideration Submitted by the American Chemistry Council Regarding Naphthalene Dear Ms. Price:
NTP — Naphthalene: Interim Response, April 22, 2005
Publication Date
Date: April 22, 2005 To: Ms. Courtney M. Price, Vice President, CHEMSTAR, American Chemistry Council 1300 Wilson Blvd, Arlington, Virginia 22209 Re: February 22, 2005, Request for Reconsideration Submitted by the American Chemistry Council Regarding Naphthalene Dear Ms. Price:
NTP — Vinyl Chloride: Interim Response, September 2, 2004
Publication Date
September 2, 2004 Courtney M. Price Vice President, CHEMSTAR 1300 Wilson Boulevard Arlington, VA 22209 Re: Request for Correction of Information submitted by the American Chemistry Council to NIH Dear Ms. Price:
NTP — Report on Carcinogens: Interim Response, July 7, 2004
Publication Date
July 7, 2004 Jim J. Tozzi Center for Regulatory Effectiveness Suite 700 11 DuPont Circle Washington, D.C. 20036 Re: Request for Correction of Information submitted by the Center for Regulatory Effectiveness to NIH Dear Mr. Tozzi:
NTP — Report on Carcinogens: Request for Correction (RFC)
Publication Date
June 28, 2004 Associate Director for Communications Office of the Director National Institutes of Health Building 1, Room 344 9000 Rockville Pike Bethesda, MD 20892 Re: Information Quality Act Request for Correction of Information: RoC Procedures Dear Sir or Madam:
NTP — Atrazine: Request for Correction(RFC)
Publication Date
July 16, 2004 Associate Director for Communications Office of the Director National Institutes of Health Building 1, Room 344 9000 Rockville Pike Bethesda, MD 20892 Re: Information Quality Act Request for Correction of Information: Atrazine Dear Sir or Madam:
NTP — Atrazine: Interim Response, Date: May 16, 2005
Publication Date
Date: May 16, 2005 To: Jim J. Tozzi, Center for Regulatory Effectiveness, Suite 700, DuPont Circle Washington, D.C. 20036 Re: Request for Correction ofInformation submitted by the Center for Regulatory Effectiveness to NIH Dear Mr. Tozzi:
NTP — Atrazine: HHS Response to RFC, May 25, 2005
Publication Date
Date: May 25, 2005 To Mr. Jim Tozzi, Center for Regulatory Effectiveness Dear Mr. Tozzi: From: National Institutes of Health, National Institute of Environmental Health Sciences
NTP — Atrazine: Interim Response, March 14, 2005
Publication Date
From: Public Health Service, Nalional lnstitutes of Health, Office of Communications and Public Liaison Date: March 14, 2005 To: Jim J. Tozzi, Center for Regulatory Effectiveness Re: Request for Correction ofInforrnation submitted by the Center for Regulatory Effectiveness to NIH Dear Mr. Tozzi:
NTP — Atrazine: Interim Response, August 26, 2005
Publication Date
Date: August 26, 2005 To: Jim J. Tozzi, Center for Regulatory Effectiveness Re: June 24, 2005, Request for Reconsideration submitted by the Center for Regulatory Effectiveness on Atrazine Dear Mr. Tozzi:
NTP — Atrazine: Request for Reconsideration (RFR)
Publication Date
Date: June 24, 2005 Associate Director for Communications Office of the Director National Institutes of Health INFORMATION QUALITY APPEAL(By Hand Delivery) Dear Sir or Madam: By this document, we appeal the denial of our request for correction (“RFC”) under the Information Quality Act (“IQA”).1